NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...

The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced perip ...

Peripheral neuropathy: a condition that can cause tingling, numbness, and pain in the extremities, especially the feet and ...

In 2004, a research group at Peking University First Hospital discovered a mutation in the gene coding for a sodium-channel ...

In a healthcare industry that has become inundated with physicians who overprescribe pain medication and are all too eager to ...

A study shows pain coping skills training (PCST) significantly alleviates chronic pain in dialysis patients, enhancing their quality of life.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 supplements.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.